r.vukovic
TL2 Moderator · Rijeka
Contributes reviews on supplier material. Based in Rijeka.
Joined 8 August 2025 · last posted 5d
86 posts, newest first. Showing up to 150.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #103 · Access › International · 23 Jul 2026 · 19 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Packaging that arrived damaged: documenting it properly Replied, post #46 · Sourcing › Logistics · 20 Jul 2026 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #48 · Access › Insurance & coverage · 20 Jul 2026 · 8 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
A pooled estimate that changed when one trial was added Replied, post #22 · Evidence › Meta-analyses · 12 Jul 2026 · 9 likes This follows post #19 rather than contradicting it. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #53 · Clinical › Comorbidities · 11 Jul 2026 · 0 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #114 · Evidence › Journal club · 8 Jul 2026 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Constipation management, with a dietitian's contribution Replied, post #87 · Practice › Side effects · 3 Jul 2026 · 0 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
What I would want from a home test that does not exist yet Replied, post #25 · Analytics › Home & field testing · 2 Jul 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
NHS criteria and how they are applied in practice Replied, post #3 · Regional › UK & Ireland · 14 Jun 2026 · 12 likes On the opening post — agreed on the reasoning, with one qualification. Private prescribing is legal and widespread, including through remote consultation. Pharmacies…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #27 · Analytics › Home & field testing · 29 May 2026 · 15 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Transporting a vial for a weekend away — a second dataset Replied, post #65 · Practice › Storage & stability · 27 May 2026 · 1 like Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #85 · Practice › Side effects · 26 May 2026 · 16 likes Worth separating two things that post #81 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Research-use-only status: what it means legally and practically Replied, post #45 · Compounds › Other compounds · 20 May 2026 · 5 likes I read post #43 twice before replying, because I had assumed the opposite. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #6 · Pharmacology › Pharmacokinetics · 18 May 2026 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #60 · Practice › Administration · 17 May 2026 · 16 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Why this subcategory is stricter about sourcing than most Replied, post #30 · Compounds › Secretagogues & GH axis · 15 May 2026 · 10 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
Reimbursement variation across member states Replied, post #12 · Regional › European Union · 5 May 2026 · 8 likes On post #8 — agreed on the reasoning, with one qualification. Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #59 · Sourcing › Logistics · 3 May 2026 · 26 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Sample handling between despatch and injection Replied, post #52 · Analytics › Method validation · 19 Apr 2026 · 24 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #67 · Evidence › Trials · 12 Apr 2026 · 2 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Transporting a vial for a weekend away — a second dataset Replied, post #25 · Practice › Storage & stability · 10 Apr 2026 · 1 like On post #21 — agreed on the reasoning, with one qualification. Temperature excursions: if a vial sat at room temperature for a time, the question is whether the…
-
List price versus negotiated price versus what you pay Replied, post #10 · Access › Pricing · 8 Apr 2026 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #22 · Evidence › Journal club · 5 Apr 2026 · 15 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
A site rotation scheme that is easy enough to actually follow Replied, post #33 · Practice › Administration · 3 Apr 2026 · 18 likes Worth separating two things that post #29 runs together. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous…
-
How to ask about something you suspect is a bad idea Replied, post #70 · Start Here › How to Ask · 28 Mar 2026 · 0 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Grapefruit: why this class is not the class that cares Replied, post #75 · Practice › Interactions · 24 Mar 2026 · 14 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #3 · Wellbeing › Sleep · 15 Mar 2026 · 0 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
-
Revisiting: Maintainer handover: how it works Replied, post #6 · Meta › Wiki maintenance · 19 Feb 2026 · 20 likes Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites resolution rather than conflict.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #19 · Analytics › Mass spectrometry · 12 Feb 2026 · 0 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #25 · Outcomes › Progress reports · 9 Feb 2026 · 9 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #4 · Outcomes › Progress reports · 4 Feb 2026 · 0 likes On post #2 — agreed on the reasoning, with one qualification. Medication changes: escalating dose, or adding or removing other medications, can affect the rate of…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #32 · Sourcing › Logistics · 3 Feb 2026 · 13 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #37 · Practice › Side effects · 16 Jan 2026 · 3 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Why "add 2 mL" is not an instruction Replied, post #25 · Practice › Reconstitution · 5 Jan 2026 · 0 likes Coming back to post #23, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #26 · Sourcing › Vendor reports · 1 Jan 2026 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #13 · Sourcing › Independent verification · 13 Dec 2025 · 12 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Tracking a preprint to publication: a worked example Replied, post #7 · Evidence › Preprints · 29 Nov 2025 · 0 likes I read post #5 twice before replying, because I had assumed the opposite. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are…
-
Publishing an inconvenient result: a case study — the long version Replied, post #43 · Sourcing › Independent verification · 20 Nov 2025 · 0 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Cost per delivered dose, which is the number that matters Replied, post #23 · Access › Pricing · 19 Nov 2025 · 5 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
Whether protein timing matters at a large deficit Replied, post #3 · Nutrition & Training › Protein & intake · 16 Nov 2025 · 29 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #52 · Analytics › Home & field testing · 12 Nov 2025 · 13 likes post #51 answers the question as asked. The question underneath it is different. What you can use home tests for: confirmation that a solution contains peptide (as…
-
What a purity-only report leaves out Replied, post #63 · Sourcing › Independent verification · 27 Oct 2025 · 17 likes post #62 is right about the mechanism and I think understates the practical bit. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
A 40-week log with the measurement method stated Replied, post #7 · Outcomes › Progress reports · 13 Oct 2025 · 28 likes post #6 is right about the mechanism and I think understates the practical bit. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #15 · Clinical › Bloodwork · 11 Oct 2025 · 1 like Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #48 · Analytics › COA interpretation · 7 Oct 2025 · 32 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Revisiting: German, French and Dutch differences, compared Replied, post #83 · Regional › European Union · 7 Oct 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Thyroid function tests during substantial weight change Replied, post #41 · Clinical › Bloodwork · 25 Aug 2025 · 9 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #4 · marked as the solution · Sourcing › Regulatory · 24 Aug 2025 · 8 likes post #2 answers the question as asked. The question underneath it is different. Why this category is maintained as documentation, not as recommendations: the goal is…
-
A preprint whose numbers changed substantially at publication — what changed since Replied, post #2 · Evidence › Preprints · 23 Aug 2025 · 14 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #30 · Pharmacology › Receptor biology · 22 Aug 2025 · 1 like Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #5 · Clinical › Special populations · 1 Aug 2025 · 2 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Are there stupid questions here? A staff answer, at length Replied, post #6 · Start Here › Welcome · 22 Jul 2025 · 2 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
What this community means by "a source", in practical terms Replied, post #22 · Start Here › Welcome · 2 Jul 2025 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #14 · Compounds › Semaglutide · 2 Jul 2025 · 3 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Half-life, steady state, and accumulation worked through Replied, post #79 · Pharmacology › Pharmacokinetics · 7 Jun 2025 · 0 likes Picking up post #76: that is the part I would want checked first. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability.…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #14 · Practice › Reconstitution · 22 May 2025 · 9 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Specification in the result column: why that is a meaningful error Replied, post #2 · Analytics › COA interpretation · 20 May 2025 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #27 · Research Methods › N-of-1 designs · 20 May 2025 · 1 like When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
Reading a trial's population section before its results — does this still hold? Replied, post #100 · Evidence › Trials · 13 May 2025 · 9 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #28 · Outcomes › Body composition · 11 May 2025 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #35 · Clinical › Comorbidities · 8 May 2025 · 0 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Subcutaneous absorption kinetics and site differences Replied, post #2 · Pharmacology › Pharmacokinetics · 8 May 2025 · 2 likes Worth separating two things that the opening post runs together. Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment,…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #44 · Compounds › Retatrutide · 30 Apr 2025 · 8 likes Coming back to post #42, because the follow-up matters more than the original answer. Mass and identity: a report on retatrutide should state the mass detected by…
-
Follow-up: Documentation that appears only after payment Replied, post #32 · Sourcing › Red flags · 29 Apr 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Metformin co-administration and additive GI effects Replied, post #17 · Practice › Interactions · 27 Apr 2025 · 29 likes Picking up post #14: that is the part I would want checked first. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #56 · Practice › Reconstitution · 24 Apr 2025 · 10 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #66 · Compounds › Tirzepatide · 21 Apr 2025 · 16 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #45 · Evidence › Journal club · 19 Apr 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Retatrutide dose escalation in the published trials Replied, post #145 · Compounds › Retatrutide · 17 Apr 2025 · 0 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Scheduled maintenance and what will be unavailable Replied, post #100 · Meta › Announcements · 7 Apr 2025 · 11 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Publishing an inconvenient result: a case study Replied, post #3 · Sourcing › Independent verification · 29 Mar 2025 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Fibre intake when total intake falls, and the constipation link Replied, post #43 · Nutrition & Training › Protein & intake · 22 Mar 2025 · 27 likes Coming back to post #41, because the follow-up matters more than the original answer. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to…
-
About the Cold chain category Replied, post #5 · Devices › Cold chain · 2 Mar 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #20 · Pharmacology › Receptor biology · 28 Feb 2025 · 30 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #76 · Compounds › Semaglutide · 24 Feb 2025 · 29 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
A newcomer's list of things that confused me, and the fixes Replied, post #5 · Start Here › Welcome · 1 Feb 2025 · 1 like I read post #3 twice before replying, because I had assumed the opposite. The moderation log is public. Every staff action is logged with the rule cited and the…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 16 Jan 2025 · 17 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #17 · Practice › Dosing & titration · 12 Jan 2025 · 3 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #136 · Analytics › COA interpretation · 1 Dec 2024 · 0 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Why "any advice?" is the least effective ending for a post Replied, post #2 · Start Here › How to Ask · 31 Oct 2024 · 9 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
How to ask for a dose change without antagonising anyone — what changed since Started this topic · Clinical › Prescriber conversations · 21 Oct 2024 · 10 likes How to ask for a dose change without antagonising anyone — what changed since — that is the question, and I have not found it answered plainly anywhere I have looked.…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #15 · Practice › Interactions · 9 Oct 2024 · 0 likes Coming back to post #13, because the follow-up matters more than the original answer. Supplements and herbs: many have no established interaction. Some do. If you are…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #16 · Evidence › Journal club · 13 Aug 2024 · 8 likes post #15 answers the question as asked. The question underneath it is different. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #35 · Safety › Contraindications · 26 Jul 2024 · 0 likes Worth separating two things that post #31 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #39 · Evidence › Journal club · 18 Jul 2024 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Cold packs, phase-change material, and what survives ten days Replied, post #118 · Sourcing › Logistics · 18 Jul 2024 · 0 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…